MEP of the week

Lobby organisation

GSK

Business / industry · Health & pharma · HQ: United Kingdom · Transparency Register entry

As of 9 September 2026, GSK appears in 45 declared MEP meetings (26 different MEPs), most often with European People's Party.

45
declared meetings
with current MEPs
26
MEPs met
€1.0M/yr
declared lobbying spend
self-reported to the register
3.3
lobbyists
full time equivalent

In their own words

“GSK is a global biopharmaceutical company with the purpose to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 45 declared meetings, by the meeting MEP's political group.

European People's Party1738%
Socialists & Democrats1431%
Renew Europe1124%
European Conservatives & Reformists12%
Patriots for Europe12%
The Left12%

Meetings by year

Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (13 in 2024).

2020
4
2021
3
2022
0
2023
5
2024
13
2025
13
2026
7

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tiemo Wölken
5 meetings · S&D
Dolors Montserrat
4 meetings · EPP
Nicolás González Casares
4 meetings · S&D
Stine Bosse
4 meetings · Renew
Tomislav Sokol
3 meetings · EPP

The 15 most recent declared meetings

DateMEPSubject
23 Jun 2026Mario FuroreBiotech act
27 May 2026Tiemo WölkenBiotech Act
26 May 2026Katri Kulmunibiotech I
4 May 2026Vytenis Povilas AndriukaitisBiotech Act
7 Apr 2026Wouter BekeEU Biotech Act I
12 Mar 2026Stine BosseBiotech Act
3 Mar 2026Tomislav SokolHealth policy
7 Nov 2025Stine BosseAntimicrobial resistance policy
23 Oct 2025Liesbet SommenPharmaceutical legislation + Critical Medicines Act
16 Oct 2025Billy KelleherPharmaceutical Issues
13 Oct 2025Tiemo WölkenPharma Regulation - Incentives for Antimicrobials
3 Sep 2025Hildegard BenteleBiotech
17 Jul 2025Tiemo WölkenPharma Package
1 Jul 2025Nicolás González CasaresBiotech
11 Jun 2025Alessandra Morettipublic health

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.